ArticleClinical and experimental hepatology2017

Ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype in the Republic of Belarus.

Dzmitry Danilau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.